evaluation, after which the Respondent was sent home pending the results of testing. The
Facility received the test findings on February 2, 2021, which it attached to the Report.‘

4, By letter dated February 19, 2021, the Board informed the Respondent that
it was in receipt of the Facility’s Report and that it had opened an investigation on her as a
result. The Board directed the Respondent to provide a response to the Report on or before
February 26, 2021.

5. By letter dated March 1, 2021, the Respondent submitted a written response
to the Board in which she stated that due to increased stressors in her life, she became
“easily influenced by a negative person in [her] life” and has since asked the Facility for
assistance for her medical condition.

6. Board staff interviewed the Facility staff persons who supervised the
Respondent at the Facility. Those individuals confirmed that they encountered the
Respondent on January 22, 2021 and observed her sleeping in a break room while on duty.
The Director confirmed that the Respondent made disclosures to her about her use of an
illicit CDS and was “remorseful” and “embarrassed,” after which she sent the Respondent
to the Facility’s Occupational Health department. Board staff confirmed during these
interviews that on January 22, 2021, the Respondent had been seeing patients during her

shift.

4 For confidentiality reasons, the test findings will not be identified in this document. The Board was aware
of the specific test findings and Panel A was aware of the findings at the time it voted to summarily suspend
the Respondent’s license.
